Vital Signals, a three-year-old startup, announces the $399 Signal ring, a smart ring that tracks blood pressure continuously rather than through intermittent cuff measurements. The company says its technology uses an algorithm to generate blood pressure readings from the ring’s sensors and that, in tests, the results are as accurate as those from a traditional arm cuff. Vital Signals positions the product as a tool for people managing hypertension and other cardiac-related conditions, aiming to make ongoing monitoring easier for consumers and potentially for clinical use. The company also indicates that beyond monitoring, its longer-term goal is to support medical diagnoses, though it does not specify a timeline in the available reporting. If the company can deliver consistent performance and broader availability, the ring would represent a step beyond many existing consumer wearables by providing continuous blood pressure data. The announcement highlights the challenge of translating continuous physiological signals into reliable blood pressure estimates, and it frames the ring as an initial consumer-facing entry point toward more advanced healthcare capabilities.